These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22917275)

  • 1. A retrospective chart review of terminal patients with cancer with agitation and their risk factors.
    Nagase M; Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Okishiro N; Oono Y; Tsugane M; Takagi T; Uejima E
    J Palliat Med; 2012 Nov; 15(11):1185-90. PubMed ID: 22917275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for agitation severity of hyperactive delirium in terminally ill cancer patients in a general hospital using ordered logistic regression analysis.
    Kanbayashi Y; Hatano Y; Hata Y; Morita T; Fukui K; Hosokawa T
    J Palliat Med; 2013 Sep; 16(9):1020-5. PubMed ID: 23888304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study.
    Morita T; Tsunoda J; Inoue S; Chihara S; Oka K
    Palliat Med; 2001 May; 15(3):197-206. PubMed ID: 11407191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agitation and delirium at the end of life: "We couldn't manage him".
    Breitbart W; Alici Y
    JAMA; 2008 Dec; 300(24):2898-910, E1. PubMed ID: 19109118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agitated terminal delirium and association with partial opioid substitution and hydration.
    Morita T; Tei Y; Inoue S
    J Palliat Med; 2003 Aug; 6(4):557-63. PubMed ID: 14516497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: prevalence and identification of research focus.
    Morita T; Tei Y; Inoue S
    J Pain Symptom Manage; 2003 Sep; 26(3):827-34. PubMed ID: 12967731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delirium prevention in terminal cancer: assessment of a multicomponent intervention.
    Gagnon P; Allard P; Gagnon B; Mérette C; Tardif F
    Psychooncology; 2012 Feb; 21(2):187-94. PubMed ID: 22271539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delirium in terminally ill cancer patients.
    Massie MJ; Holland J; Glass E
    Am J Psychiatry; 1983 Aug; 140(8):1048-50. PubMed ID: 6869591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe, refractory agitation with a haloperidol drip.
    Fernandez F; Holmes VF; Adams F; Kavanaugh JJ
    J Clin Psychiatry; 1988 Jun; 49(6):239-41. PubMed ID: 3379030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delirium and agitation at the end of life.
    Hosker CM; Bennett MI
    BMJ; 2016 Jun; 353():i3085. PubMed ID: 27283962
    [No Abstract]   [Full Text] [Related]  

  • 11. Agitation during prolonged mechanical ventilation at a long-term acute care hospital: risk factors, treatments, and outcomes.
    O'Connor H; Al-Qadheeb NS; White AC; Thaker V; Devlin JW
    J Intensive Care Med; 2014; 29(4):218-24. PubMed ID: 23753245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Delirium in Corticosteroid-Treated Patients with Advanced Cancer: An Exploratory, Multicenter, Prospective, Observational Study.
    Matsuo N; Morita T; Matsuda Y; Okamoto K; Matsumoto Y; Kaneishi K; Odagiri T; Sakurai H; Katayama H; Mori I; Yamada H; Watanabe H; Yokoyama T; Yamaguchi T; Nishi T; Shirado A; Hiramoto S; Watanabe T; Kohara H; Shimoyama S; Aruga E; Baba M; Sumita K; Iwase S
    J Palliat Med; 2017 Apr; 20(4):352-359. PubMed ID: 28379811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for developing delirium in older patients admitted to general medical wards.
    Srinonprasert V; Pakdeewongse S; Assanasen J; Eiamjinnasuwat W; Sirisuwat A; Limmathuroskul D; Praditsuwan R
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S99-104. PubMed ID: 21721434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Your postop patient is confused and agitated--next steps?
    Ng J; Pan CX; Geube A; Tan C; Kawai F; Chorost M
    J Fam Pract; 2015 Jun; 64(6):361-6. PubMed ID: 26172628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delirium in patients with cancer at the end of life.
    Cobb JL; Glantz MJ; Nicholas PK; Martin EW; Paul-Simon A; Cole BF; Corless IB
    Cancer Pract; 2000; 8(4):172-7. PubMed ID: 11898256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients.
    Morita T; Tei Y; Tsunoda J; Inoue S; Chihara S
    J Pain Symptom Manage; 2001 Dec; 22(6):997-1006. PubMed ID: 11738162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delirium, agitation, and symptom distress within the final seven days of life among cancer patients receiving hospice care.
    de la Cruz M; Noguera A; San Miguel-Arregui MT; Williams J; Chisholm G; Bruera E
    Palliat Support Care; 2015 Apr; 13(2):211-6. PubMed ID: 24556057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of delirium in critically ill patients with elevated C-reactive protein.
    Zhang Z; Pan L; Deng H; Ni H; Xu X
    J Crit Care; 2014 Feb; 29(1):88-92. PubMed ID: 24120090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenomenology of the subtypes of delirium: phenomenological differences between hyperactive and hypoactive delirium.
    Boettger S; Breitbart W
    Palliat Support Care; 2011 Jun; 9(2):129-35. PubMed ID: 24468480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of postoperative delirium in patients with esophageal cancer.
    Takeuchi M; Takeuchi H; Fujisawa D; Miyajima K; Yoshimura K; Hashiguchi S; Ozawa S; Ando N; Shirahase J; Kitagawa Y; Mimura M
    Ann Surg Oncol; 2012 Nov; 19(12):3963-70. PubMed ID: 22699802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.